Arcellx, Inc.
ACLXDelisted Apr 28, 2026- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001786205
Arcellx, Inc. was delisted on Apr 28, 2026; its insiders filed their last Form 4 on Apr 28, 2026; 240 institutions reported holding it in 13F filings for Q1 2026, worth $6.52B in total; Soros Fund Management was the only superinvestor holding it.
Superinvestors holding ACLX, Q1 2026
1 superinvestor reports holding Arcellx, Inc. on Form 13F, worth $23.0M in total. Weight is Arcellx, Inc.'s share of each 13F portfolio; actions compare shares with Q4 2025.
| Superinvestor | % of portfolio | Shares | Value | vs. previous quarter |
|---|---|---|---|---|
| Soros Fund ManagementGeorge Soros | 0.3% | 200,000 | $23.0M | New |
Moves by quarter
Superinvestors that opened, added to, trimmed or sold out of ACLX each quarter, comparing shares with the quarter before. A superinvestor that didn't file for a quarter isn't listed, and isn't counted as selling.
Q1 2026
1 superinvestor holding at quarter end
Q1 2025
0 superinvestors holding at quarter end
- Sold out
- Duquesne Family Office
Q1 2024
1 superinvestor holding at quarter end